Analysis of the arrhythmogenic substrate in human heart failure

Cardiovascular Pathology

Volumn 22, Issue 2, 2013, Pages 133-140

  Partemi, Sara ^a,b   Batlle, Montserrat ^a   Berne, Paola ^a   Berruezo, Antonio ^a   Campos, Begoña ^a   Mont, Luis ^a   Riuró, Helena ^c   Roig, Eulalia ^d   Pérez Villa, Felix ^a   Ortiz, Jose ^a   Pascali, Vincenzo L ^b   Oliva, Antonio ^b   Brugada, Ramon ^c   Brugada, Josep ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF GIRONA   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Fibrosis; Heart failure; Ischemia; KCND3; mRNA; Real Time PCR; SCN5A

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; MESSENGER RNA; POTASSIUM CHANNEL; SODIUM CHANNEL;

ARRHYTHMOGENESIS; ARTICLE; AUTOPSY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; COLLAGEN; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; NAV1.5 VOLTAGE-GATED SODIUM CHANNEL; RISK FACTORS; RNA, MESSENGER; SHAL POTASSIUM CHANNELS;

EID: 84873412339     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2012.07.003     Document Type: Article

References (40)

1. W.G Stevenson, and M.O Sweeney Arrhythmias and sudden death in heart failure Jpn Circ J 61 1997 727 740
2. W Rosamond, K Flegal, K Furie, A Go, K Greenlund, N Haase, SM Hailpern, M Ho, V Howard, B Kissela, S Kittner, D Lloyd-Jones, M McDermott, J Meigs, C Moy, G Nichol, C O'Donnell, V Roger, P Sorlie, J Steinberger, T Thom, M Wilson, and Y Hong Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 117 2008 e25 e146
3. JN Cohn, GR Johnson, R Shabetai, H Loeb, F Tristani, T Rector, R Smith, and R Fletcher Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group Circulation 87 1993 VI5 VI16
4. WG Stevenson, LW Stevenson, HR Middlekauff, and LA Saxon Sudden death prevention in patients with advanced ventricular dysfunction Circulation 88 1993 2953 2961
5. S Goldman, G Johnson, JN Cohn, G Cintron, R Smith, and G Francis Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group Circulation 87 1993 VI24 VI31
6. AM Keogh, DW Baron, and JB Hickie Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation Am J Cardiol 65 1990 903 908
7. WG Stevenson, LW Stevenson, HR Middlekauff, GC Fonarow, MA Hamilton, MA Woo, LA Saxon, PD Natterson, A Steimle, and JA Walden Improving survival for patients with advanced heart failure: a study of 737 consecutive patients J Am Coll Cardiol 26 1995 1417 1423
8. MJ Janse Electrophysiological changes in heart failure and their relationship to arrhythmogenesis Cardiovasc Res 61 2004 208 217
9. GF Tomaselli, and DP Zipes What causes sudden death in heart failure? Circ Res 95 2004 754 763
10. G Michael, L Xiao, XY Qi, D Dobrev, and S Nattel Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis Cardiovasc Res 81 2009 491 499
11. RD Nass, T Aiba, GF Tomaselli, and FG Akar Mechanisms of disease: ion channel remodeling in the failing ventricle Nat Clin Pract Cardiovasc Med 5 2008 196 207
12. SM Pogwizd Focal mechanisms underlying ventricular tachycardia during prolonged ischemic cardiomyopathy Circulation 90 1994 1441 1458
13. AR Misier, T Opthof, NM van Hemel, JT Vermeulen, JM de Bakker, JJ Defauw, FJ van Capelle, and MJ Janse Dispersion of 'refractoriness' in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction Circulation 91 1995 2566 2572
14. M Attin, RE Ideker, and SM Pogwizd Mechanistic insights into ventricular arrhythmias from mapping studies in humans Heart Rhythm 5 2008 S53 S58
15. J Borlak, and T Thum Hallmarks of ion channel gene expression in end-stage heart failure FASEB J 17 2003 1592 1608
16. S Kaab, J Dixon, J Duc, D Ashen, M Nabauer, DJ Beuckelmann, G Steinbeck, D McKinnon, and GF Tomaselli Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density Circulation 98 1998 1383 1393
17. J Akai, N Makita, H Sakurada, N Shirai, K Ueda, A Kitabatake, K Nakazawa, A Kimura, and M Hiraoka A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome FEBS Lett 479 2000 29 34
18. B Benito, J Brugada, R Brugada, and P Brugada Brugada syndrome Rev Esp Cardiol 62 2009 1297 1315
19. T Makiyama, M Akao, K Tsuji, T Doi, S Ohno, K Takenaka, A Kobori, T Ninomiya, H Yoshida, M Takano, N Makita, F Yanagisawa, Y Higashi, Y Takeyama, T Kita, and M Horie High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations J Am Coll Cardiol 46 2005 2100 2106
20. LL Shang, AE Pfahnl, S Sanyal, Z Jiao, J Allen, K Banach, J Fahrenbach, D Weiss, WR Taylor, AM Zafari, and SC Dudley Human heart failure is associated with abnormal C-terminal splicing variants in the cardiac sodium channel Circ Res 101 2007 1146 1154
21. BC Berk, K Fujiwara, and S Lehoux ECM remodeling in hypertensive heart disease J Clin Invest 117 2007 568 575
22. H Tomita, MP Vawter, DM Walsh, SJ Evans, PV Choudary, J Li, KM Overman, ME Atz, RM Myers, EG Jones, SJ Watson, H Akil, and WE Bunney Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain Biol Psychiatry 55 4 2004 Feb 15 346 352
23. P Preece, and NJ Cairns Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance Brain Res Mol 118 1-2 2003 Oct 21 60 71
24. M Nabauer, and S Kaab Potassium channel down-regulation in heart failure Cardiovasc Res 37 1998 324 334
25. CC Shieh, M Coghlan, JP Sullivan, and M Gopalakrishnan Potassium channels: molecular defects, diseases, and therapeutic opportunities Pharmacol Rev 52 2000 557 594
26. S Nattel, Y Frelin, N Gaborit, C Louault, and S Demolombe Ion-channel mRNA-expression profiling: Insights into cardiac remodeling and arrhythmic substrates J Mol Cell Cardiol 48 2010 96 105
27. JM Pinto, and PA Boyden Electrical remodeling in ischemia and infarction Cardiovasc Res 42 1999 284 297
28. GF Tomaselli, and E Marban Electrophysiological remodeling in hypertrophy and heart failure Cardiovasc Res 42 1999 270 283
29. AD Wickenden, R Kaprielian, Z Kassiri, JN Tsoporis, R Tsushima, GI Fishman, and PH Backx The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure Cardiovasc Res 37 1998 312 323
30. S Kaab, HB Nuss, N Chiamvimonvat, B O'Rourke, PH Pak, DA Kass, E Marban, and GF Tomaselli Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure Circ Res 78 1996 262 273
31. A Schroeter, S Walzik, S Blechschmidt, V Haufe, K Benndorf, and T Zimmer Structure and function of splice variants of the cardiac voltage-gated sodium channel Na(v)1.5 J Mol Cell Cardiol 49 2010 16 24
32. JA Camacho, S Hensellek, JS Rougier, S Blechschmidt, H Abriel, K Benndorf, and T Zimmer Modulation of Nav1.5 channel function by an alternatively spliced sequence in the DII/DIII linker region J Biol Chem 281 2006 9498 9506
33. R Onkal, JH Mattis, SP Fraser, JK Diss, D Shao, K Okuse, and MB Djamgoz Alternative splicing of Nav1.5: an electrophysiological comparison of 'neonatal' and 'adult' isoforms and critical involvement of a lysine residue J Cell Physiol 216 2008 716 726
34. S Zicha, VA Maltsev, S Nattel, HN Sabbah, and AI Undrovinas Post-transcriptional alterations in the expression of cardiac Na+ channel subunits in chronic heart failure J Mol Cell Cardiol 37 2004 91 100
35. CR Valdivia, WW Chu, J Pu, JD Foell, RA Haworth, MR Wolff, TJ Kamp, and JC Makielski Increased late sodium current in myocytes from a canine heart failure model and from failing human heart J Mol Cell Cardiol 38 2005 475 483
36. CA Ufret-Vincenty, DJ Baro, WJ Lederer, HA Rockman, LE Quinones, and LF Santana Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure J Biol Chem 276 2001 28197 28203
37. JA McCrohon, JC Moon, SK Prasad, WJ McKenna, CH Lorenz, AJ Coats, and DJ Pennell Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance Circulation 108 2003 54 59
38. S Nazarian, DA Bluemke, AC Lardo, MM Zviman, SP Watkins, TL Dickfeld, GR Meininger, A Roguin, H Calkins, GF Tomaselli, RG Weiss, RD Berger, JA Lima, and HR Halperin Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy Circulation 112 2005 2821 2825
39. DG Strauss, RH Selvester, JA Lima, H Arheden, JM Miller, G Gerstenblith, E Marban, RG Weiss, GF Tomaselli, GS Wagner, and KC Wu ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis Circ Arrhythm Electrophysiol 1 2008 327 336
40. KC Wu, RG Weiss, DR Thiemann, K Kitagawa, A Schmidt, D Dalal, S Lai, DA Bluemke, G Gerstenblith, E Marban, GF Tomaselli, and JA Lima Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 2414 2421